Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors

Open access
Ferrada, Carla, Moreno, Estefanía, Casadó, Vicent, Bongers, Gerold, Cortés, Antoni, Mallol, Josefa, Canela, Enric I, Leurs, Rob, Ferré, Sergi, Lluís, Carme, Franco, Rafael·2009·British Journal of Pharmacology

Abstract

Background and purpose: Functional interactions between the G protein‐coupled dopamine D 1 and histamine H 3 receptors have been described in the brain. In the present study we investigated the existence of D 1–H 3 receptor heteromers and their biochemical characteristics. Experimental approach: D 1–H 3 receptor heteromerization was studied in mammalian transfected cells with Bioluminescence Resonance Energy Transfer and binding assays. Furthermore, signalling through mitogen‐activated protein kinase (MAPK) and adenylyl cyclase pathways was studied in co‐transfected cells and compared with cells transfected with either D 1 or H 3 receptors. Key results: Bioluminescence Resonance Energy Transfer and binding assays confirmed that D 1 and H 3 receptors can heteromerize. Activation of histamine H 3 receptors did not lead to signalling towards the MAPK pathway unless dopamine D 1 receptors were co‐expressed. Also, dopamine D 1 receptors, usually coupled to G s proteins and leading to increases in cAMP, did not couple to G s but to G i in co‐transfected cells. Furthermore, signalling via each receptor was blocked not only by a selective antagonist but also by an antagonist of the partner receptor. Conclusions and implications: D 1–H 3 receptor heteromers constitute unique devices that can direct dopaminergic and histaminergic signalling towards the MAPK pathway in a G s‐independent and G i‐dependent manner. An antagonist of one of the receptor units in the D 1–H 3 receptor heteromer can induce conformational changes in the other receptor unit and block specific signals originating in the heteromer. This gives rise to unsuspected therapeutic potentials for G protein‐coupled receptor antagonists.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00152.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 162

Metadata

Authors
Ferrada, C., Moreno, E., Casadó, V., Bongers, G., Cortés, A., Mallol, J., Canela, E. I., Leurs, R., Ferré, S., Lluís, C., & Franco, R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2009-04-08
Volume
157
Issue
1
Pages
64-75
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1878860530
Cited by
162
References
2
FWCI
3.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00152.x
The paper
Ferrada, C., Moreno, E., Casadó, V., Bongers, G., Cortés, A., Mallol, J., Canela, E. I., Leurs, R., Ferré, S., Lluís, C., & Franco, R. (2009). Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00152.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.